UBS Upgrades Teva Pharma (TEVA) to Buy, 'Everything deserves a fresh start'

November 27, 2023 12:27 AM EST Send to a Friend
(Updated - November 27, 2023 3:40 AM EST)

UBS analyst Ashwani Verma upgraded Teva Pharma (NYSE: TEVA) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login